SPL 4.17% 10.0¢ starpharma holdings limited

Viraleze Availability in UK (or lack of), page-30

  1. 9,398 Posts.
    lightbulb Created with Sketch. 878
    current supply via amazon is batch lot 29960 exp 2025-06.
    could you have a look at yours and previous and see what they are please.
    Just keeping an eye out for changes in packaging and insert that I suspect may happen when / if new stock is ever packaged.

    The discounts offered direct are not major in the big picture and people buying via amazon prime with free delivery and next day would probably never look at the poorly promoted company site IMO

    Following up on post market studies there has been some references recently to how some are used in regards to off label uses especially when for a medicine the original cohorts studied were restrictive especially with medical history and other treatments however post market are often much less restrictive better representing general population. Biggest problem is limited numbers involved.and small pharma only doing just enough and being budget limited not seeing upside in gaining more data.

    Also a big push to eventually make it a legislated requirement that all studys forced to report and publish results so there is a larger database of failures so further funds can be better allocated and less duplication in the future especially highlighting poor design and using outdated comparitors . This would help all pharma better power their trials .

    Last edited by Teddyward: 06/08/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.